Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Michael D Deel

Assistant Professor of Pediatrics
Pediatrics, Hematology-Oncology
Duke University, Box 102382, Durham, NC 27710
Duke University Medical Center, Box 102382, Durham, NC 27710

Selected Grants


Vulnerabilities in the transcriptional program of fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2026

Novel vulnerabilities within PAX3-FOXO1 transcriptional programming for fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Hyundai Hope on Wheels · 2020 - 2023

A novel and rationale drug combination in preclincial models of rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Alex's Lemonade Stand · 2023 - 2023

Preclinical studies of NUAK kinase inhibitors in fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by National Pediatric Cancer Foundation, Inc. · 2021 - 2023

Investigating co-activator TAZ as a regulator of PAX3-FOXO1, cancer cell stemness, and chemoresistance in fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2018 - 2021

Vulnerabilities in the transcriptional program of fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2026

Novel vulnerabilities within PAX3-FOXO1 transcriptional programming for fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Hyundai Hope on Wheels · 2020 - 2023

A novel and rationale drug combination in preclincial models of rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by Alex's Lemonade Stand · 2023 - 2023

Preclinical studies of NUAK kinase inhibitors in fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by National Pediatric Cancer Foundation, Inc. · 2021 - 2023

Investigating co-activator TAZ as a regulator of PAX3-FOXO1, cancer cell stemness, and chemoresistance in fusion-positive rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by V Foundation for Cancer Research · 2018 - 2021

Novel regulators of checkpoint adaptation in fusion-positive rhabdomyosarcoma

FellowshipCo-Mentor · Awarded by Alex's Lemonade Stand · 2021 - 2021

Investigating the role of the transcriptional coactivator TAZ in alveolar rhabdomyosarcoma

ResearchPrincipal Investigator · Awarded by St. Baldrick's Foundation · 2016 - 2019